title: Effect of creatine phosphate on the contractile activity in acutely failing rat heart.
abstract: The hypothesis was tested that infusion of a solution containing creatine phosphate (CP) into rats with acutely failing hearts would enhance recovery of cardiac function. The acutely failing heart was produced by constricting the ascending aorta. This overload produced failure in approximately 25 min. At the point of failure the constriction was removed and solutions containing sterile physiological saline (PSS), PSS and CP, PSS and creatine, or PSS and creatine plus phosphate were infused. Cardiac function was assessed from systolic and diastolic blood pressure, +/- dp/dt, heart rate, and cardiac work. Ca2+ uptake by isolated sarcoplasmic reticulum and the concentrations of selected blood and tissue metabolites were measured. Normal cardiac function was restored in the PSS-CP infused rats whereas all other treatments did not restore cardiac function. Adenosine triphosphate and CP had declined in the myocardium of the failing hearts while lactate was elevated. The concentrations of these metabolites were normal in the PSS-CP infused animals. The glycogen concentration in the myocardium was reduced following the constriction. Ca2+ uptake by isolated sarcoplasmic reticulum was depressed in the failed hearts but normal in the hearts of CP-infused animals. These results demonstrate that the infusion of CP into animals with failing hearts can be effective in restoring cardiac function.
authors.affiliation: Department of Veterinary and Comparative Anatomy, Pharmacology, and Physiology College of Veterinary Medicine, Washington State University, Pullman 99164-6410, WA, USA.
authors.forename: P
authors.initials: P
authors.lastname: Kôrge
authors.forename: M L
authors.initials: ML
authors.lastname: Silber
authors.forename: P D
authors.initials: PD
authors.lastname: Gollnick
mesh_terms: D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D005069:Evaluation Studies as Topic; D006333:Heart Failure / Q000188:drug therapy*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D017202:Myocardial Ischemia / Q000188:drug therapy; D010725:Phosphocreatine / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley